142 related articles for article (PubMed ID: 37693261)
1. Ephrin-A4 Ligand (EFNA4) Predicts Poor Prognosis of Hepatocellular Carcinoma and Promotes Tumor Proliferation.
Ye P; Chen Z; Lou H; Mai Y; Zhu X; Fu X
J Clin Exp Hepatol; 2023; 13(5):767-773. PubMed ID: 37693261
[TBL] [Abstract][Full Text] [Related]
2. EFNA4 promotes cell proliferation and tumor metastasis in hepatocellular carcinoma through a PIK3R2/GSK3β/β-catenin positive feedback loop.
Lin J; Zeng C; Zhang J; Song Z; Qi N; Liu X; Zhang Z; Li A; Chen F
Mol Ther Nucleic Acids; 2021 Sep; 25():328-341. PubMed ID: 34484860
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma.
Huang S; Dong C; Zhang J; Fu S; Lv Y; Wu J
Front Mol Biosci; 2022; 9():943384. PubMed ID: 36052169
[No Abstract] [Full Text] [Related]
4. Interference of EFNA4 suppresses cell proliferation, invasion and angiogenesis in hepatocellular carcinoma by downregulating PYGO2.
Yuan W; Zhao H; Zhou A; Wang S
Cancer Biol Ther; 2022 Dec; 23(1):1-12. PubMed ID: 36404439
[TBL] [Abstract][Full Text] [Related]
5. Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells.
Chen YL; Yen YC; Jang CW; Wang SH; Huang HT; Chen CH; Hsiao JR; Chang JY; Chen YW
Sci Rep; 2021 Jan; 11(1):644. PubMed ID: 33436772
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis.
Zhao X; Chen Y; Sun X; He Z; Wu T; Wu C; Chen J; Wang J; Diao K; Liu XS
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077763
[TBL] [Abstract][Full Text] [Related]
7. Molecular Analysis of Ephrin A4 and Ephrin B1 in a Rabbit Model of Craniosynostosis: Likely Exclusion as the Loci of Origin.
Taylor GM; Cooper GM; Losee JE; Mooney MP; Gilbert J
Cleft Palate Craniofac J; 2018 Aug; 55(7):1020-1025. PubMed ID: 28135115
[TBL] [Abstract][Full Text] [Related]
8. An impaired transendothelial migration potential of chronic lymphocytic leukemia (CLL) cells can be linked to ephrin-A4 expression.
Trinidad EM; Ballesteros M; Zuloaga J; Zapata A; Alonso-Colmenar LM
Blood; 2009 Dec; 114(24):5081-90. PubMed ID: 19828693
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.
Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J
Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633
[TBL] [Abstract][Full Text] [Related]
10. CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
Zhong X; Kan A; Zhang W; Zhou J; Zhang H; Chen J; Tang S
Aging (Albany NY); 2019 Aug; 11(15):5483-5497. PubMed ID: 31375643
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
12. Upregulated calcium-binding tyrosine phosphorylation-regulated protein-a/b regulates cell proliferation and apoptosis and predicts poor prognosis in hepatocellular carcinoma.
Yu XN; Guo HY; Liu TT; Zhang GC; Zhu HR; Shi X; Song GQ; Jiang XM; Huang XX; Weng SQ; Dong L; Shen XZ; Huang YQ; Zhu JM
J Cell Biochem; 2020 Apr; 121(4):2938-2949. PubMed ID: 31692072
[TBL] [Abstract][Full Text] [Related]
13. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
14. Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC).
Mai Q; Sheng D; Chen C; Gou Q; Chen M; Huang X; Yin H; Chen X; Chen Z
Aging (Albany NY); 2020 Nov; 12(24):25395-25411. PubMed ID: 33229626
[TBL] [Abstract][Full Text] [Related]
15. Leucine zipper downregulated in cancer 1 may serve as a favorable prognostic biomarker by influencing proliferation, colony formation, cell cycle, apoptosis, and migration ability in hepatocellular carcinoma.
Chen H; Chen S; Chen C; Li A; Wei Z
Front Genet; 2022; 13():900951. PubMed ID: 35957693
[No Abstract] [Full Text] [Related]
16. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
Luo Y; Lin J; Zhang Y; Dai G; Li A; Liu X
Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of miR-3607 predicts prognosis of hepatocellular carcinoma and regulates tumor cell proliferation, migration and invasion.
Dou W; Yang M; Su Y; Xie R
Diagn Pathol; 2020 May; 15(1):54. PubMed ID: 32404179
[TBL] [Abstract][Full Text] [Related]
18. CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis.
Jin AL; Zhang CY; Zheng WJ; Xian JR; Yang WJ; Liu T; Chen W; Li T; Wang BL; Pan BS; Li Q; Cheng JW; Wang PX; Hu B; Zhou J; Fan J; Yang XR; Guo W
Clin Transl Med; 2022 Apr; 12(4):e794. PubMed ID: 35384345
[TBL] [Abstract][Full Text] [Related]
19. Oncogene Delta/Notch-Like EGF-Related Receptor Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma and Predicts a Poor Prognosis.
Liang Y; Luo H; Zhang H; Dong Y; Bao Y
Cancer Biother Radiopharm; 2018 Nov; 33(9):380-386. PubMed ID: 30235011
[TBL] [Abstract][Full Text] [Related]
20. LncRNA THAP9-AS1 highly expressed in tissues of hepatocellular carcinoma and accelerates tumor cell proliferation.
Su Y; Xie R; Xu Q
Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102025. PubMed ID: 36170961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
